Prenetics Global (PRE) EBIT (2021 - 2026)

Prenetics Global has disclosed EBIT across 6 years of filings, most recently posting -$8.9 million for Q1 2026.

• In Q1 2026, EBIT fell 48.48% year-over-year to -$8.9 million; the TTM figure through Mar 2026 stood at -$36.6 million (down 1.77% YoY), while the FY2025 annual figure was -$44.5 million, down 22.64% from the prior year.
• EBIT grew to -$8.9 million in Q1 2026, from -$11.5 million in the prior quarter.
• Over the last five years, EBIT for PRE reached as high as $67.3 million in Q1 2022 and fell as low as -$22.8 million in Q2 2022.
• The 5-year median for EBIT is -$11.5 million (2025), against an average of -$7.3 million.
• The widest YoY moves for EBIT: up 117.92% in 2022, down 218.68% in 2022.
• A 5-year view of EBIT shows it stood at -$11.7 million in 2022, then tumbled by 31.26% to -$15.4 million in 2023, then rose by 20.11% to -$12.3 million in 2024, then gained by 6.25% to -$11.5 million in 2025, then advanced by 23.0% to -$8.9 million in 2026.
• According to Business Quant data, EBIT over the past three periods registered -$8.9 million, -$11.5 million, and -$6.2 million for Q1 2026, Q4 2025, and Q3 2025 respectively.